Bone morphogenetic protein gene therapy

Tord D. Alden, Peter Varady, David F. Kallmes, John A. Jane, Gregory A. Helm*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

56 Scopus citations


Study Design. A retrospective analysis of previous BMP gene therapy and general gene therapy publications. Objective. To present the potential role of BMP gene therapy for the induction of osteogenesis and spinal fusion. Summary of Background Data. A variety of viral and non-viral techniques have been utilized to insert foreign transgenes into cells, both in vivo and in vitro. These techniques are now being used to transduce cells with a BMP gene to express significant amounts of BMP. This secreted BMP can subsequently stimulate osteogenesis in a variety of locations, including in the paraspinal regions. Methods. A retrospective analysis of the literature. Results. Direct and ex vivo BMP gene therapy has been shown to successfully promote bone healing and regeneration in a variety of animal models. Long-term and regulated transgene expression are clear advantages of BMP gene delivery, compared to direct BMP application. To date, BMP gene delivery with adenoviral vectors have been the most effective approach for stimulating bone induction in vivo. Conclusions. Although BMP gene therapy techniques have significant potential for the treatment of spine pathology, further preclinical and clinical research and development are required before this technology will have direct clinical applications.

Original languageEnglish (US)
Pages (from-to)S87-S93
Issue number16 SUPPL.
StatePublished - Aug 15 2002


  • Adenovirus
  • BMPs
  • Gene therapy
  • Osteogenesis
  • Spinal fusion
  • Stem cells

ASJC Scopus subject areas

  • Clinical Neurology
  • Orthopedics and Sports Medicine


Dive into the research topics of 'Bone morphogenetic protein gene therapy'. Together they form a unique fingerprint.

Cite this